A notable advancement in glucose care is emerging with the introduction of tirzepatide at a dosage of 45mg. This innovative offering builds upon the existing success of tirzepatide, a dual GIP and GLP-1 target, and https://bookmarktiger.com/story21309360/revolutionary-approach-tirzepatide-dose-for-diabetes-control